BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2591267)

  • 1. [Serum complement composition of myasthenia gravis].
    Hao ZS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Jun; 22(3):141-3, 190. PubMed ID: 2591267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor.
    Wyatt RJ; Bridges RB; Halatek DG
    J Clin Lab Immunol; 1981 Sep; 6(2):131-5. PubMed ID: 7288869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
    Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
    Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
    Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
    Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of C1 esterase inhibitor in ST-elevation myocardial infarction in patients who underwent surgical reperfusion: a randomised double-blind study.
    Fattouch K; Bianco G; Speziale G; Sampognaro R; Lavalle C; Guccione F; Dioguardi P; Ruvolo G
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):326-32. PubMed ID: 17576071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of C1-esterase inhibitor during emergency coronary artery bypass surgery in acute ST-elevation myocardial infarction.
    Thielmann M; Marggraf G; Neuhäuser M; Forkel J; Herold U; Kamler M; Massoudy P; Jakob H
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):285-93. PubMed ID: 16829095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6.
    Biesecker G; Gomez CM
    J Immunol; 1989 Apr; 142(8):2654-9. PubMed ID: 2703710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A shared effect of abscesses and nonviable tissue influencing the development of sepsis and acute respiratory distress syndrome.
    Heideman M
    Acta Chir Scand Suppl; 1982; 508():295-302. PubMed ID: 6952692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1-INH and C3/C4 levels do not correlate with long-term danazole dosage and HAE-1 attack-free interval.
    Schneider LA; Maetzke J; Staib G; Scharffetter-Kochanek K
    Allergy; 2005 Sep; 60(9):1214-5. PubMed ID: 16076313
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A; Komoly S; Bózsik B; Szobor A
    Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
    Kapp A; Wokalek H; Schöpf E
    Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
    Alsenz J; Loos M
    Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of complement in atopic dermatitis.
    Kapp A; Schöpf E
    Acta Derm Venereol Suppl (Stockh); 1985; 114():152-4. PubMed ID: 3923750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of hereditary angioneurotic edema provoked by functional insufficiency of C1-inactivator].
    Didkovskiĭ NA; Paskhina TS; Rabinovich SE; Nartikova VF; Dvoretskiĭ LI
    Ter Arkh; 1989; 61(6):116-9. PubMed ID: 2799695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.